Appetite loss in cancer patients leading to inadequate nutritional intake and weight loss.
Loss of appetite and reduced food intake occurring in cancer patients, often caused by tumor metabolites, chemotherapy, or psychological factors. This condition significantly impacts nutritional status and treatment tolerance.
Cancer-related anorexia, also called cancer cachexia syndrome when combined with weight loss, is a multifactorial condition affecting 50-80% of advanced cancer patients. It results from inflammatory cytokines released by tumors, treatment side effects, altered taste perception, early satiety, and emotional distress. Unlike simple appetite loss, cancer anorexia involves metabolic changes that prevent normal appetite restoration through nutrition alone. This condition weakens immune function, reduces treatment tolerance, and worsens patient outcomes.
Represents a major nutritional challenge that compromises the body's ability to maintain muscle mass, immune function, and treatment response capacity.
Offer small, frequent meals rich in protein and calories. Use oral nutritional supplements when food intake is insufficient. Consult nutritionists and consider appetite stimulants prescribed by oncologists. Address psychological factors through supportive care.
Managing cancer-related anorexia requires multidisciplinary strategies combining nutritional support, medical intervention, and psychological care to maintain adequate nutrient intake.
A question about Cancer-Related Anorexia? Ask our nutrition AI.
Ask a question